RESULTS OF DECISION POINT ONE
RESULTS OF DECISION POINT TWO
Guidance to Student
The client has a complex neuropathic pain syndrome that may never respond to pain medication. Once that is understood, the next task is to explain to the client that pain level expectations need to be realistic in nature and understand that he will always have some level of pain on a daily basis. The key is to manage it in a manner that allows him to continue his activities of daily living with as little discomfort as possible. Next, it is important to explain that medications are never the final answer but a part of a complex regimen that includes physical therapy, possible chiropractic care, heat and massage therapy, and medications. Savella is a SNRI that also possesses NMDA antagonist activity which helps in producing analgesia at the site of nerve endings. It is specifically marketed for fibromyalgia and has a place in therapy for this gentleman. Tramadol is never a good option along with other opioid type analgesics. Agonists at the Mu receptors does not provide adequate pain control in these types of neuropathic pain syndromes and therefore is never a good idea. It also has addictive properties which can lead to secondary drug abuse. Reductions in Savella can help control side effects but at a cost of uncontrolled pain. It is always a good idea to start with dose reductions during parts of the day that pain is most under control. The addition of Celexa with Savella needs to be done cautiously. Both medications inhibit the reuptake of serotonin and can, therefore, lead to serotonin toxicity or serotonin syndrome.
Guidance to Student
The client has a complex neuropathic pain syndrome that may never respond to pain medication. Once that is understood, the next task is to explain to the client that pain level expectations need to be realistic in nature and understand that he will always have some level of pain on a daily basis. The key is to manage it in a manner that allows him to continue his activities of daily living with as little discomfort as possible. Next, it is important to explain that medications are never the final answer but a part of a complex regimen that includes physical therapy, possible chiropractic care, heat and massage therapy, and medications. Savella is a SNRI that also possesses NMDA antagonist activity which helps in producing analgesia at the site of nerve endings. It is specifically marketed for fibromyalgia and has a place in therapy for this gentleman. Tramadol is never a good option along with other opioid type analgesics. Agonists at the Mu receptors does not provide adequate pain control in these types of neuropathic pain syndromes and therefore is never a good idea. It also has addictive properties which can lead to secondary drug abuse. Reductions in Savella can help control side effects but at a cost of uncontrolled pain. It is always a good idea to start with dose reductions during parts of the day that pain is most under control. The addition of Celexa with Savella needs to be done cautiously. Both medications inhibit the reuptake of serotonin and can, therefore, lead to serotonin toxicity or serotonin syndrome.
Guidance to Student
The client has a complex neuropathic pain syndrome that may never respond to pain medication. Once that is understood, the next task is to explain to the client that pain level expectations need to be realistic in nature and understand that he will always have some level of pain on a daily basis. The key is to manage it in a manner that allows him to continue his activities of daily living with as little discomfort as possible. Next, it is important to explain that medications are never the final answer but a part of a complex regimen that includes physical therapy, possible chiropractic care, heat and massage therapy, and medications. Savella is a SNRI that also possesses NMDA antagonist activity which helps in producing analgesia at the site of nerve endings. It is specifically marketed for fibromyalgia and has a place in therapy for this gentleman. Tramadol is never a good option along with other opioid type analgesics. Agonists at the Mu receptors does not provide adequate pain control in these types of neuropathic pain syndromes and therefore is never a good idea. It also has addictive properties which can lead to secondary drug abuse. Reductions in Savella can help control side effects but at a cost of uncontrolled pain. It is always a good idea to start with dose reductions during parts of the day that pain is most under control. The addition of Celexa with Savella needs to be done cautiously. Both medications inhibit the reuptake of serotonin and can, therefore, lead to serotonin toxicity or serotonin syndrome.
RESULTS OF DECISION POINT TWO
Guidance to Student
From the above description provided, it sounds as if the client may be experiencing some depressive symptomatology. In cases of depression, we worry about suicide ideation. You should evaluate this with the client. With this in mind, amitriptyline in overdoses can cause fatal cardiac arrhythmias and should never be dispensed in quantities larger than a 7-day supply to clients in this state. Some would argue that the class (TCA) should not be used at all in this client (even attempting to be cautious and dispensing 7 days at a time could result in the client stock-piling the pills for a fatal overdose).
Although not all SSRIs are FDA approved or indicated for treatment of neuropathic pain, they do have a role to play due to their activity within the central nervous system and the their effects on the serotonergic pathway. Since this client is clearly showing signs of dependence (he used a 30 day supply of medication in 21 days) and possible abuse; continuation of Lyrica, a DEA schedule V medication, would not be in the best interest of the client and should, therefore, be discontinued immediately.
Guidance to Student
From the above description provided, it sounds as if the client may be experiencing some depressive symptomatology. In cases of depression, we worry about suicide ideation. You should evaluate this with the client. With this in mind, amitriptyline in overdoses can cause fatal cardiac arrhythmias and should never be dispensed in quantities larger than a 7-day supply to clients in this state. Some would argue that the class (TCA) should not be used at all in this client (even attempting to be cautious and dispensing 7 days at a time could result in the client stock-piling the pills for a fatal overdose).
Although not all SSRIs are FDA approved or indicated for treatment of neuropathic pain, they do have a role to play due to their activity within the central nervous system and the their effects on the serotonergic pathway. Since this client is clearly showing signs of dependence (he used a 30 day supply of medication in 21 days) and possible abuse; continuation of Lyrica, a DEA schedule V medication, would not be in the best interest of the client and should, therefore, be discontinued immediately.
Guidance to Student
From the above description provided, it sounds as if the client may be experiencing some depressive symptomatology. In cases of depression, we worry about suicide ideation. You should evaluate this with the client. With this in mind, amitriptyline in overdoses can cause fatal cardiac arrhythmias and should never be dispensed in quantities larger than a 7-day supply to clients in this state. Some would argue that the class (TCA) should not be used at all in this client (even attempting to be cautious and dispensing 7 days at a time could result in the client stock-piling the pills for a fatal overdose).
Although not all SSRIs are FDA approved or indicated for treatment of neuropathic pain, they do have a role to play due to their activity within the central nervous system and the their effects on the serotonergic pathway. Since this client is clearly showing signs of dependence (he used a 30 day supply of medication in 21 days) and possible abuse; continuation of Lyrica, a DEA schedule V medication, would not be in the best interest of the client and should, therefore, be discontinued immediately.
RESULTS OF DECISION POINT TWO
Guidance to Student
Anxiety induction is one of the most bothersome side effects of an SSRI in the initiation phases of therapy. Some clients, without proper counseling, will stop taking the medication because they perceive it as getting worse. Difficulty acquiring and maintaining an erection is another side effect with SSRI therapy that can be bothersome to male clients. Unfortunately, this side effect is not transient such as the anxiety. The usual course of action will include counseling and the addition of another medication (such as Wellbutrin) to help manage the sexual side effect. Another option is to discontinue the Zoloft and start a new medication but SSRI’s work well for neuropathic pain. In this situation, the addition of another medication to help manage this particular side effect would be prudent. Increasing the dose alone will do nothing to address the side effects and will only lead to non-compliance and a fractured therapeutic alliance with the client.
Guidance to Student
Anxiety induction is one of the most bothersome side effects of an SSRI in the initiation phases of therapy. Some clients, without proper counseling, will stop taking the medication because they perceive it as getting worse. Difficulty acquiring and maintaining an erection is another side effect with SSRI therapy that can be bothersome to male clients. Unfortunately, this side effect is not transient such as the anxiety. The usual course of action will include counseling and the addition of another medication (such as Wellbutrin) to help manage the sexual side effect. Another option is to discontinue the Zoloft and start a new medication but SSRI’s work well for neuropathic pain. In this situation, the addition of another medication to help manage this particular side effect would be prudent. Increasing the dose alone will do nothing to address the side effects and will only lead to non-compliance and a fractured therapeutic alliance with the client.
Guidance to Student
Anxiety induction is one of the most bothersome side effects of an SSRI in the initiation phases of therapy. Some clients, without proper counseling, will stop taking the medication because they perceive it as getting worse. Difficulty acquiring and maintaining an erection is another side effect with SSRI therapy that can be bothersome to male clients. Unfortunately, this side effect is not transient such as the anxiety. The usual course of action will include counseling and the addition of another medication (such as Wellbutrin) to help manage the sexual side effect. Another option is to discontinue the Zoloft and start a new medication but SSRI’s work well for neuropathic pain. In this situation, the addition of another medication to help manage this particular side effect would be prudent. Increasing the dose alone will do nothing to address the side effects and will only lead to non-compliance and a fractured therapeutic alliance with the client.